Annual Meeting 2024 Posters

Along with keynote talks, research presentations by VALIDATE-funded projects, and time for networking, we aim to hold a Poster Session at the Annual Meeting, so that more VALIDATE members can showcase their research.

We will be adding to the as we get closer to the Annual Meeting 2024. 

 

Asst Prof Kiran Afshan

Quaid-i-Azam University, Pakistan

Epidemiological Distribution of Cutaneous Leishmaniasis in Pakistan (abstract)

 

 

Dr Luciana Balboa

Academia Nacional de Medicina de Buenos Aires, Argentina

The Inhibition of HIF-1α Limits the Migration of Dendritic Cells to Lymph Nodes in BCG-Vaccinated Mice (abstract)

 

 

Dr Suraj Bhattarai

Global Health Research & Medical Interventions for Development (GLOHMED), Nepal

Burden of Melioidosis in Nepal: A Prospective Cross-Sectional Pilot Study in Two Provinces(abstract)

 

 

Asst Prof Jelalu Kemal Birmeka

Haramaya University College of Vet Medicine, Ethiopia

The Effect of Ensete ventricosum (false banana) Corm Extract against Nephrotoxicity in Mice Caused by Anti-tuberculosis Drugs Administration (abstract)

 

 

Ms Suzzana Buabeng

Stellenbosch University, South Africa

Assessment of the Pharmacological Modulation of the Acute and Chronic Immune Response to Mycobacterium tuberculosis Infection via the CaMK1δ Inhibitor CS0640 in a Diet-Induced Prediabetes Murine Model (abstract)

 

 

Dr Naomi Daniels

University of Otago, New Zealand

Evasion of BCG-mediated Immune Protection by Hypervirulent Strains of Mycobacterium tuberculosis (abstract)

 

 

Dr Fatoumatta Darboe

University of California San Francisco (UCSF), USA

Immune Pathogenesis of TB Disease and Impact of HIV Infection on risk of TB Disease Progression (abstract)

 

 

Dr Lahari Das

Albert Einstein College of Medicine, United States of America (USA)

A Novel Recombinant Herpes Simplex Virus -2 based Vaccine Against Tuberculosis (abstract)

 

 

Mr Nicky de Vrij

Institute of Tropical Medicine Antwerp, Belgium

The Human Immunopeptidome of Cutaneous Leishmaniasis Across the Clinical Spectrum: New Targets for Vaccine Design? (abstract)

 

 

Dr Chyntia Díaz Acosta

National University of Asuncion (IICS-UNA), Paraguay

Exploring the Role of M. leprae PGL-I as a Lipid Droplet-inducing Molecule in Schwann cells. (abstract)

 

 

Ms Fatou Faal

MRC The Gambia at LSHTM, Gambia

Investigating West Africa Circulating Mycobacterium tuberculosis Complex Lineages Response to Anti-Tuberculosis Treatment Approaches (abstract)

 

 

Dr Wynand Goosen

Stellenbosch University, South Africa

Identification and Molecular Characterization of Mycobacterium bovis DNA in GeneXpert® MTB/RIF Ultra-Positive, Culture-Negative Sputum Samples from a Rural Community in South Africa (abstract)

 

 

Dr Nancy Hilda J

ICMR-National Institute for Research in Tuberculosis (ICMR-NIRT), India

Immunosenescence and Inflammation in Cured Tuberculosis Patients: Implications for Revaccination Program (abstract)

 

 

Mr Toheeb Jumah

University Mohammed VI Polytechnic (UM6P), Morocco

In Silico Screening of Potential Inhibitors of Mycobacterium tuberculosis Mycolic Acid Cell Wall Development Using Mullein weed Bioactive Compounds (abstract)

 

 

Dr Rajiv Kumar

Banaras Hindu University, India

Persistence of Leishmania-specific T-cell Responses in People Cured of Visceral Leishmaniasis (abstract)

 

 

Miss Millicent Naa Koshie Lamptey

KCCR & KNUST, Ghana

BCG-Vaccinated Children with Contact to Tuberculosis Patients Show Delayed Conversion of Mycobacterium tuberculosis-Specific IFN-γ Release (abstract)

 

 

Mr Shamsuddeen Ma'aruf

Stellenbosch University, South Africa

Anti-mycobacterial Efficacy of Curdlan-Functionalized Nanoparticles and their Influence on Macrophage Phenotype in vitro (abstract)

 

 

Dr Suzie Madaki

Bayero University, Nigeria

Influence of Single Nucleotide Polymorphism of INF-γ (rs.2430561, +874 A/T) on the Risk of Tuberculosis and Susceptibility to Treatment in Kaduna State, Nigeria (abstract)

 

 

Dr Ugochukwu Madubueze

Federal Teaching Hospital Abakaliki Ebonyi State, Nigeria

Perception of Household Heads Towards Newer Vaccines: A Qualitative Study in Rural Nigeria (abstract)

 

 

Assoc Prof Daniel Mekonnen

Bahir Dar University, Ethiopia

Comparative Whole Genome Sequence Analysis of Mycobacterium tuberculosis Isolated from Pulmonary Tuberculosis and Tuberculous Lymphadenitis Cases in Northwest Ethiopia Genomic Diversity, Transmission Dynamics and In-Silico Molecular Drug Resistance (abstract)

 

 

Dr Lydia Mosi

University of Ghana, Ghana

Pseudogenomic Insights Into the Evolution of Mycobacterium ulcerans Suggests Environmental Niche Adaptation (abstract)

 

 

 

Dr Zaynab Mousavian

Karolinska Institutet, Sweden

Protein-based Biomarker Discovery in Tuberculosis (abstract)

 

 

Dr Sarah Nyangu

Zambart, Zambia

"Ubumi Bwandi” (My health, my choice): Integrated wellness screening and prevention in Zambia (abstract)

 

 

Dr Zimvo Obasa

Stellenbosch University, South Africa

An Ex Vivo Model for Understanding the Impact of Vaccination on Mycobacterial Persister Populations (abstract)

 

 

Dr Niaina Rakotosamimanana

Pasteur Institute of Madagascar, Madagascar 

RISK6 and Sweeney3 Human Blood Transcriptomic Signatures Evaluation for Tuberculosis Diagnosis and Treatment Monitoring (abstract)    

 

 

Dr F. Javier Salguero Bodes

UK Health Security Agency (UKHSA), United Kingdom (UK)

Histopathology and Cellular Profiles of Experimental TB Granulomas in Guinea Pigs (abstract)

 

 

Dr Pia Steigler

TB Vaccine Ddevelopment: Considerations for Production in Low-and middle-income Countries (abstract)

 

 

 

Ms Garima Shekhawat

Central University of Rajasthan (CURAJ), India

Mycobacterium tuberculosis Protein Tyrosine Phosphatase B as Vaccine Candidate against Tuberculosis (abstract)

 

 

Miss Alondra Tapia

ENCB - Escuela Nacional de Ciencias Biológicas Unidad Santo Tomás IPN, Mexico

Developing Nanoparticle-Based Vaccines Against Burkholderia pseudomallei (abstract)

 

 

Ms Naffie Top

MRC The Gambia at LSHTM, Gambia

Macrophages Differentiation and Mycobacterium tuberculosis Complex Lineages Influence the Response to Tyrosine Kinase Inhibitor Erlotinib (abstract)

 

 

Miss Jessica Williams

UK Health Security Agency (UKHSA), United Kingdom (UK)

Identifying Immune Signatures Associated with Inherent Resistance to Mycobacterium tuberculosis (abstract)

 

 

Asst Prof Endalew Yizengaw

Bahir Dar University, Ethiopia

Clinical Presentations, Parasite Genotypes, Gene Expression and Immunological Profiles of Cutaneous Leishmaniasis Patients in Lay Gayint, Northwest Ethiopia (abstract)